Loading...
Market
Story
DEA to Shift Marijuana from Schedule 1 to 3, Following Biden's Directive
Apr 30, 2024, 05:35 PM
The U.S. Drug Enforcement Administration (DEA) is set to reclassify marijuana as a less dangerous drug, marking a significant shift in federal drug policy. This move will transition marijuana from a Schedule 1 to a Schedule 3 substance, acknowledging its medical uses and reducing its classification as a criminal offense. This policy change, the most substantial in over 50 years, aligns with the medical legalization in 24 states and follows a directive from President Joe Biden in October 2022 to review federal marijuana laws. The DEA's proposal also notes the drug's less potential for abuse and clarifies that it does not legalize marijuana for recreational use.
View original story
Similar markets
Decrease in support • 25%
Remain the same • 25%
Increase in support • 25%
Significant increase in support • 25%
Below 65% • 33%
65% to 74% • 34%
75% or higher • 33%
Significantly more favorable • 25%
Slightly more favorable • 25%
No significant change • 25%
Less favorable • 25%
Support exceeds 70% • 25%
Support between 50% and 70% • 25%
Support between 30% and 50% • 25%
Support below 30% • 25%
Significantly more favorable • 25%
Somewhat more favorable • 25%
No significant change • 25%
Less favorable • 25%
More positive • 33%
No significant change • 33%
More negative • 33%
Less than 50% • 33%
50-69% • 33%
70% or more • 33%
Mostly positive • 33%
Mostly negative • 33%
Mixed • 34%
Increases support for Biden • 33%
No significant impact on election • 34%
Decreases support for Biden • 33%
Support increases • 33%
Support remains stable • 33%
Support decreases • 34%
Mostly Positive • 33%
Neutral • 33%
Mostly Negative • 33%